Clinical Trials Logo

Breast Benign Tumor clinical trials

View clinical trials related to Breast Benign Tumor.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04340180 Active, not recruiting - Clinical trials for Breast Malignant Tumor

Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

Start date: July 14, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the ability of AI to correctly aid in characterization of benign and malignant lesions even when a low dose of gadolinium is administered. This study is relevant for several reasons, most notably being the reduction of MRI dose and decreased gadolinium deposition in the brain. In addition, use of AI may provide increased sensitivity and specificity for the radiologist evaluating a breast MRI exam. Half of the population will have benign pathologies and the other half will have malignant pathologies.